|
Summary: Prior to 1988, UV was not considered a viable technology to treat emerging pathogens and meet new DBP rules.
CCC's pioneering technical discovery in 1998 totally changed the prior perceptions of US and in general the approacj to meeting the new pathogen and DBP rules.
UV is the most cost effective technology for treating emerging pathogens while meeting DBP standards.
CCC continues to lead the way through continued advancements in reactor design using complex CFD based models.
If you would like to view the complete text of
this brochure, please register with
us.
|